FIM
ABMD

Freedom Investment Management’s Abiomed Inc ABMD Stock Holding History

Freedom Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,425
Closed -$3.88M – 923
2018
Q3 		$3.88M Buy
9,425
+1,175
+14% +$463K 0.24% 62
2018
Q2 		$3.37M Buy
8,250
+6,848
+488% +$2.48M 0.2% 74
2018
Q1 		$408K Sell
1,402
-764
-35% -$194K 0.02% 733
2017
Q4 		$406K Buy
2,166
+48
+2% +$8.96K 0.02% 730
2017
Q3 		$357K Sell
2,118
-2,001
-49% -$303K 0.02% 758
2017
Q2 		$590K Buy
+4,119
New +$554K 0.03% 501

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Freedom Investment Management's ABMD Position: Q4 2018 in Review

Freedom Investment Management sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 9,425 shares — an estimated $3.88M sold.

Freedom Investment Management first reported a position in ABMD in Q2 2017 and held it in 6 quarters. The position peaked at $3.88M in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Freedom Investment Management reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Freedom Investment Management sold 9,425 Abiomed Inc shares in Q4 2018, an estimated $3.88M.
  • Freedom Investment Management first reported a position in Abiomed Inc in Q2 2017 and held it in 6 quarters.
  • Freedom Investment Management's Abiomed Inc position peaked at $3.88M in Q3 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Freedom Investment Management's 13F filing for Q4 2018, filed 25 Jan 2019.